| Targeting mitochondrial function to treat optic neuropathy N Gueven, M Nadikudi, A Daniel, J Chhetri Mitochondrion 36, 7-14, 2017 | 41 | 2017 |
| Amide linked redox-active naphthoquinones for the treatment of mitochondrial dysfunction KL Woolley, M Nadikudi, MN Koupaei, M Corban, P McCartney, ... MedChemComm 10 (3), 399-412, 2019 | 17 | 2019 |
| New extractive method development of sitagliptin phosphate in API and its unit dosage forms by spectrophotometry N Monila, RP Pulla, H Shabad, V Swathi, J Rajasekhar, A Ramesh, ... IOSR Journal of Pharmacy and Biological Sciences 1 (6), 37-40, 2012 | 10 | 2012 |
| The oceans—unlocking the treasured drugs V Swathi, PR Pratap, N Monila, S Harshini, J RajaSekhar, A Ramesh International Journal of Pharmaceutical and Chemical Sciences 1, 1098-1105, 2012 | 3 | 2012 |
| Bioactivity profiles of cytoprotective short-chain quinones Z Feng, M Nadikudi, KL Woolley, AL Hemasa, S Chear, JA Smith, ... Molecules 26 (5), 1382, 2021 | 1 | 2021 |
| Terapeutiske forbindelser og fremgangsmåder N Güven, J Smith, KL Woolley, M Nadikudi | | 2023 |
| Therapeutic compounds and methods N Güven, J Smith, KL Woolley, M Nadikudi | | 2023 |
| Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction N Güven, J Smith, KL Woolley, M Nadikudi | | 2022 |
| Therapeutic compounds and methods N Güven, J Smith, KL Woolley, M Nadikudi US Patent 10,934,253, 2021 | | 2021 |
| Novel short-chain quinones against mitochondrial dysfunction M Nadikudi University Of Tasmania, 2019 | | 2019 |
| Therapeutic compounds and methods N GÜVEN, J Smith, KL WOOLLEY, M NADIKUDI | | 2018 |
